‘Cholesterol vaccine’: Twice-yearly jab could help to halve ‘bad’ cholesterol
A new treatment delivered as a regular injection could help patients with high cholesterol levels to reduce their risk of cardiovascular disease.
Scientists join forces to fight TB and HIV in EUR 12.9 million TREATS trial
Researchers have launched a ground-breaking new trial to assess the impact of combined testing and treatment for HIV and tuberculosis.
E. coli rewired to control growth as experts let them make proteins for medicine
Experts have equipped biotech workhorse bacteria with feedback control mechanism to balance growth with making protein products.
Video
Visually-impaired inventor’s dream for smart baby buggy made real by students
A baby buggy which senses its environment through technology normally used in self-driving cars has been created by a team of student engineers.
Ocean warming can predict land warming with simple model
The temperature trend of continents can be estimated by measuring warming of nearby oceans, revealing a simple behaviour of the climate system.
Feature
10 challenges for the future of robotics
With robotics on the rise, Imperial researchers look to the future, exploring everything from nature-inspired robot swarms to the ethics of AI.
Diabetes drug may not reduce risk of death
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.
Cutting salt intake in the US could save money and lives, finds study
A US policy aimed at reducing the amount of salt in people’s diets could save money and lives if properly implemented, according to new research.
Meet the weird reptiles at the short end of the evolutionary stick
Turtles that breathe through their genitals and tiny chameleons are amongst the weird reptiles heading for extinction unless urgent action is taken.
£5m grant to kickstart pioneering MedTech accelerator led by Imperial
An Imperial-led project to rapidly translate new medical technologies into clinical solutions has received £5m government funding.
